Son y\u0131llarda kanser biyolojisi alan\u0131nda yap\u0131lan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 ara\u015ft\u0131rmalar, kal\u0131tsal genetik varyantlar\u0131n t\u00fcm\u00f6r h\u00fccrelerindeki proteomik yap\u0131y\u0131 derinlemesine etkiledi\u011fine dair \u00f6nemli bulgular\u0131 ortaya koydu. Bu kapsaml\u0131 ara\u015ft\u0131rma, birden fazla kanser t\u00fcr\u00fcnde kal\u0131tsal mutasyonlar\u0131n proteom \u00fczerindeki etkilerini inceleyerek, kanser geli\u015fimi ve ilerlemesinde bu genetik fakt\u00f6rlerin oynad\u0131\u011f\u0131 rol\u00fc molek\u00fcler d\u00fczeyde ayd\u0131nlat\u0131yor. Ara\u015ft\u0131rma, \u00e7ok katmanl\u0131 \u2018omics\u2019 verilerin entegre edilmesiyle, kanser h\u00fccrelerindeki protein yap\u0131 ve i\u015fleyi\u015findeki de\u011fi\u015fikliklerin, bireylerin kal\u0131tsal genetik \u00f6zellikleri taraf\u0131ndan nas\u0131l belirlendi\u011fini g\u00f6zler \u00f6n\u00fcne seriyor.<\/p>\n
\u00d6zellikle kanser ara\u015ft\u0131rmalar\u0131 son y\u0131llarda daha \u00e7ok somatik mutasyonlar \u00fczerinde yo\u011funla\u015fm\u0131\u015ft\u0131; yani ya\u015fam boyunca edinilen ve do\u011frudan t\u00fcm\u00f6r olu\u015fumuna neden olan genetik de\u011fi\u015fiklikler. Ancak kal\u0131tsal yani germline varyantlar\u0131n kanser biyolojisi \u00fczerindeki do\u011frudan etkileri ge\u00e7mi\u015fte tam anlam\u0131yla \u00e7\u00f6z\u00fclememi\u015fti. Bahsi ge\u00e7en ara\u015ft\u0131rmada uygulanan sofistike proteogenomik yakla\u015f\u0131m, 10 farkl\u0131 kanser t\u00fcr\u00fcnden 1000\u2019den fazla hastadan elde edilen \u00e7ok b\u00fcy\u00fck veri setlerini bilgisayar destekli modellerle entegre ederek bu bilgi bo\u015flu\u011funu doldurdu. B\u00f6ylece kal\u0131tsal varyantlar\u0131n protein d\u00fczeyinde olu\u015fturdu\u011fu farkl\u0131l\u0131klar ayr\u0131nt\u0131l\u0131 \u015fekilde analiz edildi.<\/p>\n
\u00c7al\u0131\u015fmada kullan\u0131lan en \u00f6nemli veri kaynaklar\u0131ndan biri, Kanser Klinik Proteomik Analiz Konsorsiyumu (CPTAC) oldu. Bu uluslararas\u0131 i\u015f birli\u011fi, kanser dokular\u0131ndaki tamamlay\u0131c\u0131 protein repertuvarlar\u0131n\u0131 haritalamak \u00fczerine yo\u011funla\u015f\u0131yor. Ara\u015ft\u0131rmac\u0131lar, 337 binden fazla germline varyant\u0131; proteomik, transkriptomik, asetilomik ve fosfoproteomik verilerle kar\u015f\u0131la\u015ft\u0131rarak, bu varyantlar aras\u0131nda 119 genetik de\u011fi\u015fikli\u011fi \u00f6n plana \u00e7\u0131kard\u0131. Hem yayg\u0131n hem de nadir bulunan bu varyantlar, protein yap\u0131s\u0131nda, miktar\u0131nda ve i\u015flevlerini d\u00fczenleyen post-translasyonel modifikasyonlarda \u00f6nemli de\u011fi\u015fikliklere yol a\u00e7arak kanserle ili\u015fkili h\u00fccresel s\u00fcre\u00e7leri etkiliyor.<\/p>\n
Ara\u015ft\u0131rman\u0131n ba\u015far\u0131s\u0131n\u0131 sa\u011flayan en yenilik\u00e7i y\u00f6ntemlerden biri \u201cprecision peptidomics\u201d olarak adland\u0131r\u0131lan stratejidir. Bu y\u00f6ntem, geleneksel birliktelik \u00e7al\u0131\u015fmalar\u0131n\u0131n \u00f6tesine ge\u00e7erek kal\u0131tsal mutasyonlar\u0131n do\u011frudan hasta bazl\u0131 protein varyantlar\u0131 \u00fczerinde nas\u0131l etkili oldu\u011funu ortaya koydu. B\u00f6ylece, tek ba\u015f\u0131na zarars\u0131z gibi g\u00f6r\u00fcnen kal\u0131tsal varyantlar\u0131n bir araya geldi\u011finde kanser riskini art\u0131rmas\u0131n\u0131n molek\u00fcler mekanizmas\u0131 ayd\u0131nlat\u0131ld\u0131. Bu noktada proteogenomik analiz, ki\u015fiye \u00f6zg\u00fc tedavi stratejilerinin geli\u015ftirilmesinde m\u00fchim bir ara\u00e7 olarak \u00f6n plana \u00e7\u0131k\u0131yor.<\/p>\n
Ara\u015ft\u0131rman\u0131n \u00f6nemli bulgular\u0131ndan biri de kal\u0131tsal varyantlar\u0131n sadece kansere yatk\u0131nl\u0131\u011f\u0131 art\u0131rmakla kalmay\u0131p t\u00fcm\u00f6r biyolojisini de belirgin \u015fekilde \u015fekillendirmesidir. Varyantlar\u0131n etkisiyle protein kararl\u0131l\u0131\u011f\u0131 ve sinyal yolaklar\u0131 de\u011fi\u015fmekte, bunlar da h\u00fccresel homeostazda bozulmalara neden olarak t\u00fcm\u00f6r b\u00fcy\u00fcmesi ve tedavi diren\u00e7lili\u011fi gibi klinik sonu\u00e7lar\u0131 tetiklemektedir. Proteinlerin post-translasyonel modifikasyonlar\u0131nda ortaya \u00e7\u0131kan anormallikler, onkojenik sinyal kaskadlar\u0131n\u0131 harekete ge\u00e7irerek t\u00fcm\u00f6r geli\u015fimini destekliyor. Bu ayr\u0131nt\u0131l\u0131 molek\u00fcler profil, biyobelirte\u00e7 ke\u015ffi ve hasta s\u0131n\u0131fland\u0131rmas\u0131nda yeni ufuklar a\u00e7\u0131yor.<\/p>\n
\u00d6zellikle b\u00fcy\u00fck \u00f6l\u00e7ekli ve \u00e7ok disiplinli yap\u0131s\u0131 ile dikkat \u00e7eken bu ara\u015ft\u0131rma, kapsaml\u0131 veri entegrasyonu sayesinde farkl\u0131 kanser tiplerinde kal\u0131tsal varyantlar\u0131n yayg\u0131nl\u0131\u011f\u0131n\u0131 ve etkilerini ortaya koydu. 1000\u2019in \u00fczerindeki hasta ve 10 ayr\u0131 kanser t\u00fcr\u00fc ile yap\u0131lan \u00e7al\u0131\u015fma, kal\u0131tsal genetik varyantlar\u0131n kanser ilerlemesinde sadece k\u00fc\u00e7\u00fck ya da dolayl\u0131 bir rol oynad\u0131\u011f\u0131 \u00f6nermesini sorgulayarak bu alanda yeni bir paradigmaya i\u015faret ediyor. Elde edilen kan\u0131tlar, germline mutasyonlar\u0131n kanser biyolojisine derinlemesine n\u00fcfuz etti\u011fini g\u00f6steriyor.<\/p>\n
Ara\u015ft\u0131rmada Josep Carreras L\u00f6semi Ara\u015ft\u0131rma Enstit\u00fcs\u00fc\u2019nden Dr. Eduard Porta\u2019n\u0131n ortak k\u0131demli dan\u0131\u015fman, Kathleen J. Imbach\u2019\u0131n ise ortak ilk yazar olarak g\u00f6rev almas\u0131, projenin disiplinleraras\u0131 ve uluslararas\u0131 i\u015f birli\u011fi ruhunu yans\u0131t\u0131yor. \u00d6zellikle kanser imm\u00fcnojenomik alan\u0131ndaki uzmanl\u0131klar\u0131 sayesinde, kal\u0131tsal proteogenomik varyantlar\u0131n t\u00fcm\u00f6r\u00fcn ba\u011f\u0131\u015f\u0131kl\u0131k sisteminden ka\u00e7\u0131\u015f\u0131yla olan ba\u011flant\u0131lar\u0131 da inceleniyor. Bu alan, imm\u00fcnoterapi etkinli\u011finin art\u0131r\u0131lmas\u0131 y\u00f6n\u00fcnde \u00f6nemli f\u0131rsatlar sunuyor.<\/p>\n
Ara\u015ft\u0131rman\u0131n bir di\u011fer \u00f6nemli noktas\u0131 ise \u00e7ok katmanl\u0131 \u2018omics\u2019 verilerin entegre analizinin g\u00fcc\u00fcd\u00fcr. Genomik de\u011fi\u015fkenliklerin protein fonksiyonlar\u0131 ile e\u015fle\u015ftirilmesi, genotip-fenotip ili\u015fkilerinin gelenekselle\u015fmi\u015f engellerini a\u015fmakta ve sadece genomik verilerle ula\u015f\u0131lamayan ince yap\u0131sal ve i\u015flevsel de\u011fi\u015fimleri ortaya \u00e7\u0131karmakta. B\u00f6ylece onkogenezin temel mekanizmalar\u0131 \u00e7ok daha hassas bir \u015fekilde anla\u015f\u0131labiliyor ve klinik uygulamalarda b\u00fcy\u00fck fayda sa\u011flanabiliyor.<\/p>\n
Ara\u015ft\u0131rman\u0131n klinik yans\u0131malar\u0131 da umut verici. Kal\u0131tsal germline varyantlar\u0131n protein fonksiyonlar\u0131n\u0131 ve kanser riskini nas\u0131l etkiledi\u011finin anla\u015f\u0131lmas\u0131, y\u00fcksek riskli ki\u015filer i\u00e7in daha erken tespit ve ki\u015fiselle\u015ftirilmi\u015f takip programlar\u0131n\u0131n olu\u015fturulmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131lacakt\u0131r. Ayr\u0131ca varyant kaynakl\u0131 proteomik bozukluklar\u0131 hedef alan tedaviler, molek\u00fcler d\u00fczeyde yeni ila\u00e7 ke\u015fiflerine kap\u0131 a\u00e7abilir. \u00d6zellikle protein stabilitesini veya sinyalizasyon s\u00fcre\u00e7lerini normale d\u00f6nd\u00fcren ila\u00e7lar\u0131n geli\u015ftirilmesi, tedavi ba\u015far\u0131s\u0131n\u0131 art\u0131rabilir.<\/p>\n
Finansman a\u00e7\u0131s\u0131ndan uluslararas\u0131 boyutta sa\u011flanan g\u00fc\u00e7l\u00fc destek, projenin ba\u015far\u0131s\u0131ndaki temel unsurlardan biridir. ABD Ulusal Kanser Enstit\u00fcs\u00fc, \u0130spanya Bilim, Yenilik ve \u00dcniversiteler Bakanl\u0131\u011f\u0131 ile Fundaci\u00f3n Cris contra el C\u00e1ncer gibi kurumlar\u0131n yapt\u0131\u011f\u0131 katk\u0131lar, ara\u015ft\u0131rman\u0131n kapsaml\u0131 y\u00fcr\u00fct\u00fclmesini ve geni\u015f veri taban\u0131n\u0131n olu\u015fturulmas\u0131n\u0131 m\u00fcmk\u00fcn k\u0131ld\u0131. Bu t\u00fcr b\u00fcy\u00fck \u00f6l\u00e7ekli i\u015f birlikleri, kanser biyolojisinin karma\u015f\u0131k yap\u0131s\u0131n\u0131n \u00e7\u00f6z\u00fcmlenmesinde hayati \u00f6nem ta\u015f\u0131yor.<\/p>\n
Sonu\u00e7 olarak, bu \u00e7al\u0131\u015fma kanserin kal\u0131tsal temellerinin ke\u015ffedilmesinde \u00f6nemli bir kilometre ta\u015f\u0131d\u0131r. Kal\u0131tsal varyantlar\u0131n, kanser proteomunu ne denli karma\u015f\u0131k ve kapsaml\u0131 bi\u00e7imde etkiledi\u011fini kan\u0131tlayarak ki\u015fiselle\u015ftirilmi\u015f onkoloji alan\u0131nda yeni bir yakla\u015f\u0131ma zemin haz\u0131rlad\u0131. Bu yakla\u015f\u0131m, sadece hastal\u0131k riskinin de\u011ferlendirilmesinde de\u011fil, ayn\u0131 zamanda molek\u00fcler profillere dayal\u0131 hedefli tedavi stratejilerinde de devrim yaratabilir.<\/p>\n
Akademik d\u00fcnyay\u0131 a\u015fan ve klinik prati\u011fe do\u011frudan yans\u0131yacak bu bulgular, milyonlarca kanser hastas\u0131 i\u00e7in umut vermektedir. Proteogenomik teknolojilerin g\u00fcnl\u00fck onkoloji uygulamalar\u0131na entegre edilmesi, erken tan\u0131, tedavi etkinli\u011fi ve hastalar\u0131n ya\u015fam s\u00fcresi bak\u0131m\u0131ndan \u00f6nemli ilerlemeler sa\u011flayacakt\u0131r. Bu \u00f6nemli \u00e7al\u0131\u015fma, disiplinleraras\u0131 bilimsel \u00e7aban\u0131n kanserin gizli molek\u00fcler belirleyicilerini ortaya \u00e7\u0131karma g\u00fcc\u00fcn\u00fc g\u00f6stermekte ve tedavi yakla\u015f\u0131mlar\u0131n\u0131n ki\u015fiye \u00f6zel hale gelmesini desteklemektedir.<\/p>\n
—<\/p>\n
**Ara\u015ft\u0131rma Konusu**: Cells
\n**Makale Ba\u015fl\u0131\u011f\u0131**: Precision proteogenomics reveals pan-cancer impact of germline variants
\n**Haberin Yay\u0131n Tarihi**: 14-Apr-2025
\n**Web References**:
\nhttps:\/\/www.carrerasresearch.org\/en\/news\/a-proteogenomic-approach-offers-the-deepest-and-broadest-view-of-what-happens-into-a-cancer-cell
\nhttps:\/\/www.cell.com\/cell\/fulltext\/S0092-8674(25)00344-7?rss=yes
\n**Doi Referans**: 10.1016\/j.cell.2025.03.026
\n**Resim Credits**: Josep Carreras Leukaemia Research Institute
\n**Anahtar Kelimeler**: Germlines, Genetic variation, Cancer research, Bioinformatics<\/p>\n","protected":false},"excerpt":{"rendered":"
Son y\u0131llarda kanser biyolojisi alan\u0131nda yap\u0131lan \u00e7\u0131\u011f\u0131r a\u00e7\u0131c\u0131 ara\u015ft\u0131rmalar, kal\u0131tsal genetik varyantlar\u0131n t\u00fcm\u00f6r h\u00fccrelerindeki proteomik yap\u0131y\u0131 derinlemesine etkiledi\u011fine dair \u00f6nemli bulgular\u0131 ortaya koydu. Bu kapsaml\u0131 ara\u015ft\u0131rma, birden fazla kanser t\u00fcr\u00fcnde kal\u0131tsal mutasyonlar\u0131n proteom \u00fczerindeki etkilerini inceleyerek, kanser geli\u015fimi ve ilerlemesinde bu genetik fakt\u00f6rlerin oynad\u0131\u011f\u0131 rol\u00fc molek\u00fcler d\u00fczeyde ayd\u0131nlat\u0131yor. Ara\u015ft\u0131rma, \u00e7ok katmanl\u0131 \u2018omics\u2019 verilerin entegre edilmesiyle,…<\/p>\n","protected":false},"author":1,"featured_media":2627,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[143,140,141,142,144],"tmauthors":[],"class_list":{"0":"post-2626","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-cptac-kanser-proteomik-verileri","9":"tag-germline-varyantlar-ve-kanser-ilerlemesi","10":"tag-kalitsal-genetik-varyantlarin-proteomik-etkileri","11":"tag-kanser-proteogenomik-analiz-yontemleri","12":"tag-precision-peptidomics-kanser-arastirmalari"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/04\/Germline-Varyantlar-ve-Kanser-Ilerlemesi-Arasindaki-Baglanti-1744745363.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/2626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=2626"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/2626\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/2627"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=2626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=2626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=2626"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=2626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}